Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
To access this article, please choose from the options below
PII: S0169-5002(09)00498-X
doi:10.1016/j.lungcan.2009.09.014
© 2009 Elsevier Ireland Ltd. All rights reserved.
